NewsBenzingaVeru、ObesityWeekで新たな結果を発表;セマグルチド投与中の肥満を有する65歳以上の高齢患者において、エノボサルムの追加により除脂肪体重と階段昇降の身体機能が維持された Veru、ObesityWeekで新たな結果を発表;セマグルチド投与中の肥満を有する65歳以上の高齢患者において、エノボサルムの追加により除脂肪体重と階段昇降の身体機能が維持された Benzinga 2026.11.17 13:37 (GMT+0) Open on Benzinga Other news Coinbase Account Connection Opens to All ChatGPT Users NVIDIA Earnings Preview: Management Transition and Whether Q4 Revenue Guidance Can Break Through $125 Billion Nvidia’s first big move after Jensen Huang’s exit targets national security Bitwise Launches AI Cybersecurity ETF ZDAY, Focusing on Companies Defending Against AI Attacks and Securing AI Systems Michael Burry Is Betting on an AI Stock Selloff. I’d Rather Buy the Dip. Hank Green is self-funding ClockwiseTV, a curated educational video platform for kids
NVIDIA Earnings Preview: Management Transition and Whether Q4 Revenue Guidance Can Break Through $125 Billion
Bitwise Launches AI Cybersecurity ETF ZDAY, Focusing on Companies Defending Against AI Attacks and Securing AI Systems